DCGO
DocGo Inc.·Healthcare
0.52
9.882%(−0.06)
Close PriceLast Updated: — ET
52W L: $0.5252W H: $2.51
DCGO NEWS
defenseworld.net
4d ago
Analysts Set DocGo Inc. (NASDAQ:DCGO) PT at $2.38
Shares of DocGo Inc. (NASDAQ: DCGO - Get Free Report) have earned an average rating of "Hold" from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company.
defenseworld.net
Apr 3
Head-To-Head Survey: DocGo (NASDAQ:DCGO) vs. CochLear (OTCMKTS:CHEOY)
DocGo (NASDAQ: DCGO - Get Free Report) and CochLear (OTCMKTS:CHEOY - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Analyst Recommendations This is a summary of recent ratings and
businesswire.com
Mar 18
Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies®
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that it has been recognized as one of the 2026 World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This is DocGo's first time receiving this honor, and the Company is one of only four honorees in the healthcare providers and ser.
seekingalpha.com
Mar 17
DocGo Inc. (DCGO) Q4 2025 Earnings Call Transcript
DocGo Inc. (DCGO) Q4 2025 Earnings Call Transcript
zacks.com
Mar 16
DocGo Inc. (DCGO) Reports Q4 Loss, Beats Revenue Estimates
DocGo Inc. (DCGO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to earnings of $0.04 per share a year ago.
businesswire.com
Mar 16
DocGo Announces Fourth Quarter and Full Year 2025 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared to $120.8 million in the fourth quarter of 2024. This decline was entirely due to the wind-down of mig.
